Molecular-Genetic Correlates of Fatigue in Cancer Patients Receiving Localized External Beam Radiation Therapy
Public ClinicalTrials.gov record NCT00852111. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Background: * Researchers have studied the causes of fatigue during treatments for various diseases, but these results have not been conclusive. * More information on the physical changes that affect the body during treatment may help identify biological or chemical factors that contribute to patient fatigue, which may allow physicians to identify individuals who may be more at risk of feeling fatigue before, during, and after treatment for diseases such as cancer. Objectives: * To identify factors contributing to fatigue in men who are undergoing radiation treatment for prostate cancer. Eligibility: * Men 18 years of age and older who are scheduled to receive localized radiation treatment for prostate cancer. Design: * Six outpatient visits to the NIH Clinical Center, approximately on the same day and same time of day: * First visit before beginning radiation treatment. * Once a week for the first 2 weeks of the treatment, once at the midpoint of treatment, once at the end of treatment. * Final visit 4 weeks after completion of radiation treatment. * Initial visit will involve a physical examination and questions about medical history. * Evaluations during the treatment period: * Blood draws to identify cells and chemicals associated with inflammation and fatigue. * Questions about physical activity, fatigue, depression, and quality of life.
Study identification
- NCT ID
- NCT00852111
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 141 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 22, 2009
- Primary completion
- Aug 23, 2021
- Completion
- Aug 23, 2021
- Last update posted
- Mar 6, 2025
2009 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00852111, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00852111 live on ClinicalTrials.gov.